Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Historical Holders from Q4 2021 to Q3 2025

Symbol
CNTX on Nasdaq
CUSIP
21077P108
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
92.2M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
68.6M
Holdings value
$45M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
39
Number of buys
13
Number of sells
-16
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPM BioImpact LLC 16.4% $8.97M 14.7M MPM BioImpact LLC Dec 31, 2024
Avidity Partners Management LP 9.9% 0% $7.94M $1.17M 9.13M +17.4% Avidity Partners Management LP Jun 30, 2025
Deep Track Capital, LP 8.27% $4.53M 7.42M Deep Track Capital, LP Mar 31, 2025
Blue Owl Capital Holdings LP 8.48% $3.88M 6.36M Blue Owl Capital Holdings LP Dec 31, 2024
GREAT POINT PARTNERS LLC 5.22% 0% $4.07M 4.68M 0% Great Point Partners, LLC Jun 30, 2025
FRANKLIN RESOURCES INC 4.5% -16% $2.44M 4M 0% Franklin Resources, Inc. Mar 31, 2025
Lehr Martin A. 2.1% $973K 1.6M Martin Lehr Dec 31, 2024

Institutional Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 113K $109K -$181K $0.97 2
2025 Q2 68.6M $45M -$1.72M $0.66 39
2025 Q1 71.4M $43.7M -$1.1M $0.61 42
2024 Q4 72.8M $76.4M +$15.8M $1.05 52
2024 Q3 56.7M $111M -$854K $1.96 42
2024 Q2 57M $114M +$107M $2.01 34
2024 Q1 3.94M $5.43M +$524K $1.38 25
2023 Q4 3.56M $4.02M +$1.1M $1.13 23
2023 Q3 2.58M $3.89M +$507K $1.51 22
2023 Q2 2.24M $3.58M +$1.63M $1.60 21
2023 Q1 1.28M $718K -$1.59M $0.56 19
2022 Q4 3.88M $2.54M -$384K $0.65 22
2022 Q3 4.13M $4.59M +$469K $1.11 21
2022 Q2 2.45M $5.13M -$1.02M $2.12 16
2022 Q1 2.9M $6.3M -$2.23M $2.17 12
2021 Q4 3.55M $9.44M +$8.49M $2.66 15